Patients' attitudes on how to deal with the risk of future stone recurrences

Urological Research

Volumn 34, Issue 4, 2006, Pages 255-260

  Tiselius, Hans Göran ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Active stone removal; Biochemical risk evaluation; Patient attitude; Pharmacological treatment; Urine analysis; Urine collection

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RECURRENT DISEASE; RISK; UROLITHIASIS;

ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RECURRENCE; RISK; URINARY CALCULI;

EID: 33750623890     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-006-0056-2     Document Type: Article

References (35)

1. Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18:397-399
2. Tiselius HG (2000) Stone incidence and prevention. Braz J Urol 26:453-462
3. Trinchieri A, Ostini F, Nespoli R, Revera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after first renal stone. J Urol 162:27-30 (Pubitemid 29420872)
4. Strohmaier WL (2004) Course of renal stone disease - an epidemiological view. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis. The Hong Kong Polytechnic University, Hong Kong (MDI Gohel), pp 377-385
5. Robertson WG, Peacock M, Nordin BEC (1968) Activity products in stone-forming and non-stone forming urine. Clin Sci 34:579-594
6. Finlayson B (1974) Renal lithiasis in review. Urol Clin North Am 1:181-211
7. Nancollas GH (1976) The kinetics of crystal growth and renal stoneformation. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. Plenum, New York, pp 5-23
8. Smith LH (1989) Medical aspects of urolithiasis: overview. J Urol 141:707-710
9. Baumann M (1990) Physico-chemical aspects of calcium stone formation. Urol Res 18:25-30
10. Hess B, Tiselius HG (2002) Physical-chemical processes in kidney stone formation. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism (2 edn) Williams & Wilkins, Lippincott, pp 619-628
11. Tiselius HG (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger G (eds) Urolithiasis 2000. Proceedings of the 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 349-355
12. Tiselius HG (2004) Routine metabolic evaluation of patients with stone disease - aspects on its cost effectiveness. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis, The Hong Kong Polytechnic University, Hong Kong, (MDI Gohel), pp 372-376
13. Tiselius HG, Advisory Board of European Urolithiasis Research EAU Health Care Office Working Party for Urolithiasis (2001) Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 88:1-16
14. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Callucci M (2001) Guidelines on urolithiasis. (Abbreviated version). Eur Urol 40:362-371
15. Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36-41 (Pubitemid 30396717)
16. Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a "common sense diet" on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 1999 36:136-143 (Pubitemid 29348802)
17. Pattras JG, Moore RG (1999) Citrate in the management of urolithiasis. J Endourol 13:687-691
18. Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069-2073 (Pubitemid 27481329)
19. Lee YH, Huang WC, Tsai JY, Hung JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453-1457 (Pubitemid 29420794)
20. Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate nephrolithiasis - a prospective randomized study. Br J Urol 73:362-365 (Pubitemid 24133555)
21. Hess B, Hasler-Strub U, Ackermann D, Jaeger Ph (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 12:1362-1368 (Pubitemid 27353024)
22. Höbarth K, Hofbauer J, Szabo N (1994) Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44:20-25
23. Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20:321-327
24. Bek-Jensen H, Tiselius HG (1998) Repeated urine analysis in patients with calcium stone disease. Eur Urol 33:323-332 (Pubitemid 28140434)
25. Tiselius HG (1997) Metabolic evaluation of patients with stone disease. Urol Int 59:131-141
26. Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167:1607-1612 (Pubitemid 34240683)
27. Grampsas SA, Moore M, Chandhoke PS (2000) 10-year experience with extracorporeal shockwave lithotripsy in the state of Colorado. J Endourol 14:711-714
28. Laerum E (1984) Recurrent urolithiasis: a general-practice study of risk factors and clinical consequences. Scand J Urol Nephrol 18:67-70
29. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthiazide reduces calcium oxalate calculus recurrences but magnesium hydroxide does not. J Urol 139:679-684
30. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H (1992) Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69:571-576
31. Borghi L, Meschi T, Guerra A, Novanni A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(suppl 6):78-86
32. Ahlstrand C, Sandwall K, Tiselius HG (1996) Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: Tiselius HG (eds) Renal stones - aspects on their formation, removal and prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Akademitryck AB, Edsbruk, pp 195-197
33. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761-1764 (Pubitemid 24350792)
34. Tuncel A, Biri H, Küpeli B, Tan Ö, Sen I (2003) Efficiency of long-term potassium citrate treatment in patients with calcium oxalate stone disease. In: Sarica K, Kyagci F, Erbagci A, Inal Y (eds) Proceedings of the 2nd Eurolithiasis Society Meeting. Abstract. ReTa offset publishing, Gaziantep, p 273
35. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M, Knoll T (2006) Guidelines on Urolithiasis. European Association of Urology (EAU Guidelines office)